INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

89 hedge funds and large institutions have $286M invested in Inozyme Pharma in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 21 reducing their positions, and 11 closing their positions.

Holders
89
Holders Change
-1
Holders Change %
-1.11%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
10
Increased
37
Reduced
21
Closed
11
Calls
$22K
Puts
$36K
Net Calls
-$14K
Net Calls Change
-$75K

Top Buyers

1
SVCM
1
Saturn V Capital Management
Texas
$7.16M
2
EAM
2
Eventide Asset Management
Massachusetts
$21.6M
3
PFCS
3
Pale Fire Capital SE
Czech Republic
$986K
4
BlackRock
4
BlackRock
New York
$18.3M
5
RSCM
5
Rock Springs Capital Management
Maryland
$19.9M

Top Sellers

1
SFM
1
Sphera Funds Management
Israel
$6.23M
2
LCM
2
Laurion Capital Management
New York
$0
3
SC
3
Samlyn Capital
New York
$17M
4
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$29.7M
5
Millennium Management
5
Millennium Management
New York
$9.12M
Name Market Value Shares Shares
Change 		Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$29.7M 5,673,629 -55,227 -1%
PBPIA
2
Pivotal bioVenture Partners Investment Advisor
California
$23.5M 4,494,851 – –
SI
3
Sofinnova Investments
California
$22.4M 4,280,308 – –
EAM
4
Eventide Asset Management
Massachusetts
$21.6M 4,134,436 +198,216 +5%
RSCM
5
Rock Springs Capital Management
Maryland
$19.9M 3,802,883 +104,509 +3%
BlackRock
6
BlackRock
New York
$18.3M 3,491,236 +148,043 +4%
SC
7
Samlyn Capital
New York
$17M 3,259,158 -91,377 -3%
AAA
8
Affinity Asset Advisors
New York
$14.8M 2,822,318 -33,934 -1%
Vanguard Group
9
Vanguard Group
Pennsylvania
$13.7M 2,624,338 -4,971 -0.2%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$13M 2,478,689 +1,262 +0.1%
NMC
11
NEA Management Company
Maryland
$12.7M 2,437,689 – –
Millennium Management
12
Millennium Management
New York
$9.12M 1,744,453 -43,494 -2%
SB
13
Samsara BioCapital
California
$8.17M 1,562,500 – –
SVCM
14
Saturn V Capital Management
Texas
$7.16M 1,368,810 +228,500 +20%
SFM
15
Sphera Funds Management
Israel
$6.23M 1,191,140 -271,584 -19%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$6.13M 1,171,172 +19,499 +2%
BOCH
17
Blue Owl Capital Holdings
New York
$5.86M 1,120,027 – –
State Street
18
State Street
Massachusetts
$5.49M 1,050,420 +50,386 +5%
WP
19
Woodline Partners
California
$5.25M 1,003,124 +2,451 +0.2%
DMKJ
20
David M. Knott Jr
$2.95M 564,549 – –
Goldman Sachs
21
Goldman Sachs
New York
$2.34M 447,317 +85,449 +24%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$2.33M 446,152 +66,088 +17%
Northern Trust
23
Northern Trust
Illinois
$2.3M 438,845 +27,469 +7%
Wellington Management Group
24
Wellington Management Group
Massachusetts
$1.36M 260,719 +27,739 +12%
UOC
25
UBS O'Connor
Illinois
$1.18M 226,232 +21,014 +10%
1
2 3 4 5